Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06DZO
|
|||
| Former ID |
DNC005555
|
|||
| Drug Name |
Dodecanoic acid adamantan-1-ylamide
|
|||
| Synonyms |
N-(1-adamantyl)dodecanamide; Dodecanoic acid adamantan-1-ylamide; CHEMBL192273; AC1NNKRI; N-adamantyl n-dodecanamide; SCHEMBL12931877; ZINC36330560; BDBM50167054
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H39NO
|
|||
| Canonical SMILES |
CCCCCCCCCCCC(=O)NC12CC3CC(C1)CC(C3)C2
|
|||
| InChI |
1S/C22H39NO/c1-2-3-4-5-6-7-8-9-10-11-21(24)23-22-15-18-12-19(16-22)14-20(13-18)17-22/h18-20H,2-17H2,1H3,(H,23,24)
|
|||
| InChIKey |
FRFKXRWIBACCCN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. J Med Chem. 2005 May 19;48(10):3621-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.